Trials / Completed
CompletedNCT00171496
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
A Six-month Open Label, Multicenter, Randomized Study to Evaluate the Incidence of New Onset Diabetes Mellitus and Glucose Metabolism in Patients Receiving Cyclosporine Microemulsion With C-2 Monitoring Versus Tacrolimus After de Novo Kidney Transplantation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 693 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the impact of tacrolimus and cyclosporine microemulsion on glucose metabolism in kidney transplant recipients and the efficacy and safety in preventing organ rejection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine microemulsion | |
| DRUG | Tacrolimus |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2006-03-01
- Completion
- 2006-03-01
- First posted
- 2005-09-15
- Last updated
- 2016-11-18
Source: ClinicalTrials.gov record NCT00171496. Inclusion in this directory is not an endorsement.